- Biogen’s New Alzheimer’s Drug Meets Slow Rollout The Wall Street Journal
- Biogen's Aduhelm sales fall dramatically below Wall Street's expectations STAT
- Biogen sells just $300,000 worth of contentious Alzheimer’s drug Financial Times
- Biogen making layoffs in Raleigh, cites delay in Alzheimer’s drug access, new tech WRAL Tech Wire
- Biogen’s Alzheimer Drug Sales Were Dismal. Earnings Are Lifting the Stock. Barron's
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/3AWf1IB
via IFTTT
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment